Calcium Gluconate Market - Forecasts from 2023 to 2028

The global calcium gluconate market was valued at US$703.846 million in 2021

Calcium gluconate is a mineral supplement that can be made by neutralizing gluconic acid with lime or calcium carbonate. Using intravenous therapy (IV) and other ways, calcium gluconate aids in the treatment of illnesses brought on by calcium shortages, such as hypocalcemia tetany, hypotension, hypocalcemia linked to hyperparathyroidism, hypocalcemia brought on by fast growth or pregnancy, and hypermagnesemia. The calcium gluconate market is expected to expand globally due to rising demand for end-use products, including medicines, and food & beverages.

Market Drivers:

Increased use of nutritional supplements to raise the calcium gluconate demand

The benefits of using calcium supplements to treat calcium deficient conditions such as hypocalcemia tetany, hypocalcemia linked to hyperparathyroidism, and hypocalcemia have increased demand for nutritional supplements for calcium gluconate market. More than 53 million Americans, according to the NIH, have osteoporosis or are at high risk of developing it because they have poor bone density. As a result, people are now taking more calcium gluconate supplements, driving the market share of calcium gluconate.

Consumption of copper gluconate supplements is increasing

Copper plays a significant role in sustaining heart rates among heart patients, and therefore, in many nations, the lack of copper is the main cause of cardiac illness. As a result, the capacity of copper gluconate supplements is growing as cases of heart illness rise, fueling the growth of calcium gluconate. Consumption of junk food by the growing population worldwide is the main factor for human vitamin deficiencies, indirectly boosting the demand for copper gluconate. The rise in eating disorders among the younger generation is upsurging the market for dietary supplements, further fueling the calcium gluconate supplements market.

Focus on investments and collaborations by key players

Investments made by participants in the calcium gluconate market will go towards acquiring new technologies, obtaining raw materials, effective procurement and inventory management, improving product portfolios, and using skills to sustain growth in difficult economic times. Manufacturers of calcium gluconate and related firms are concentrating on developing country-specific strategies since the economic and social obstacles vary greatly between various markets and nations.

Calcium lactate gluconate is anticipated to hold the maximum share

Calcium lactate gluconate is a powder that is white, crystalline, tasteless, and odorless. It has high physiological compatibility and is non-toxic. Calcium lactate gluconate has excellent bioavailability, a neutral taste, and excellent solubility. In medicines, it serves as a premium calcium source. According to scientific analyses of human research, calcium lactate gluconate increases bone mineral density more consistently and significantly than other calcium salts. It is mostly used in food processing at low temperatures, in line blending, and other applications where solubility is a delicate issue, such as clear drinks and concentrated or quick preparations. This is the main driving factor for the calcium gluconate market.

Pharmaceutical industry to be a significant applicative domain for calcium gluconate

The pharmaceutical industry accounted for the largest share of the calcium gluconate market when segmented by application due to its advantages in medical treatment. The increased demand for osteoporosis medicines is driving the market due to the changing lifestyle and inactivity. Another factor driving the calcium gluconate market is the rising demand for frozen and peeled veggies due to hectic work schedules. There has been a significant rise in consumer demand for calcium deficiency prevention products, propelling the calcium gluconate market.

North America is anticipated to be a key calcium gluconate marketplace globally

Expanding the local healthcare sector in North America is the main driver for the calcium gluconate market in the region. The production of medications for treating thyroid problems and rickets, as well as the presence of multiple manufacturers in the area, including Johnson & Johnson and Pfizer Inc., are factors propelling the calcium gluconate market growth. While due to the expanding regional food & beverage sector, Asia-Pacific is anticipated to develop at the greatest growth rate throughout the projection period. As the demand for the manufacturing of nutrient-dense foods increases with growing health awareness, the calcium gluconate market is anticipated to rise in the region.

Investment program in the United States is anticipated to propel growth

In collaboration with the Children's Investment Fund Foundation, the Nutrition Science Programme of the New York Academy of Sciences, they launched a calcium task group in April 2021. This program's major objective was to address worldwide calcium shortage and its effects on health, calcium status indicators, and calcium supplementation for expectant mothers to enhance pregnancy outcomes. Calcium supplementation, such as calcium gluconate, is frequently advised to maintain cardiovascular health since studies have revealed a potential relationship between low calcium levels and an increased risk of cardiovascular disorders. The calcium gluconate market share will increase due to the rise in heart disease fatalities.

Market Developments:

• In April 2022, Fresenius Kabi USA, announced in its news release, the launching of two new presentations of calcium gluconate. The presentations were introduced in sodium chloride injection in the company’s proprietary freeflex® ready-to-administer containers.
• In March 2022, A leading producer of fine chemicals, laboratory equipment, and supplies on a global scale, Spectrum Chemical Mfg. Corp. has announced the addition of approximately 12 additional manufacturers to its rapidly expanding range of chemicals for the production of biopharmaceuticals under the bioCERTIFIEDTM quality management system. 

Segmentation:

By Application

• Food & Beverage
• Pharmaceuticals
• Personal Care products
• Animal feed

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others